Illinois considers program to fight drug-resistant bacteria

Under bill, hospitals would be required to test for super bug

May 06, 2007|By Judith Graham | Judith Graham,Chicago Tribune

CHICAGO -- Illinois is poised to become the first state to require hospitals to implement programs combating a dangerous, drug-resistant bacterium that kills thousands of people in the U.S. each year.

Under a bill moving through the Legislature, hospitals would be required to test for methicillin-resistant Staphylococcus aureus, or MRSA, in all intensive-care and "at-risk" patients, such as those transferred from nursing homes. If it is detected, aggressive measures to prevent transmission would kick in.

MRSA is a potentially virulent bacterium that has developed strong defenses against common antibiotics such as penicillin. People can become infected in community settings such as gyms, but MRSA is most commonly acquired in health care facilities.

The drug-defying super-bug has been spreading rapidly. Nearly 11,000 Illinois hospital patients were infected last year, a 54 percent rise in just three years, according to the Illinois Hospital Association. Nationally, MRSA strikes about 126,000 hospital patients a year and kills at least 5,000 to 17,000.

"More people are infected and die of MRSA each month in hospitals in the U.S. than from severe acute respiratory syndrome [SARS], anthrax, bioterrorism agents [and] avian influenza combined," Dr. William Jarvis, the CDC's former acting director of the hospital infections program, said in written comments to a February hearing in Springfield.

No one disputes that MRSA is a pressing health concern, but the Illinois bill has sparked considerable controversy.

Critics include prominent medical specialists who argue that the legislation is too prescriptive and would impair their ability to address emerging crises. Supporters include the Illinois Hospital Association and consumer advocates, who argue that hospitals have done too little to fight MRSA, putting patients' health at risk.

Illinois lawmakers have sided strongly with advocates in the first round of votes on proposed legislation. A final vote is expected within the next month.

"Sure, hospitals and doctors don't want to be told what to do," said Jeanine Thomas, who contracted MRSA in 2000 in a Chicago hospital. "But look at how out-of-control MRSA is."

The goal of the Illinois bill is to identify people who are potential reservoirs of infection and to stop them from passing it on. Two percent to 4 percent of people admitted to hospitals carry MRSA in their noses or on their skin without displaying symptoms.

Transmission could occur when a colonized patient rubs her nose before shaking hands with the doctor who comes in for an examination. The doctor could then carry the bacteria to another patient on his hands or on equipment he handles.

To limit MRSA's spread, patients who test positive would be isolated; everyone entering a patient's room would put on sterilized gowns, gloves and masks; and strict hand-washing regimens would be instituted.

More than 140 studies have shown that the approach, called active surveillance culturing, can reduce MRSA infections in hospitals by more than 70 percent.

Nationally, the strategy is attracting attention. In March, the Department of Veterans Affairs implemented it at more than 150 hospital intensive-care units across the U.S. Several states, including Minnesota, Pennsylvania and New York, are looking at MRSA-control legislation. In January, the Hospital Corporation of America adopted similar MRSA-control measures at 165 hospitals in 20 states.

Dr. Jonathan Perlin, Hospital Corp.'s chief medical officer, said he is confident that the effort will pay off by reducing complications that result in expensive patient stays. "Everything we do to eliminate MRSA will eliminate other drug-resistant infections," Perlin said.

Under the Illinois bill, hospitals would also have to report MRSA infections annually to the state Department of Public Health, which would publish statewide data on its Web site. Currently, hospitals do not disclose MRSA infections rates either locally or nationally.

Critics worry, however, that resources devoted to MRSA detection could detract from other important efforts to improve patient safety in hospitals.

"These infections don't have to happen. We know what we need to do to prevent them. Hospitals just aren't doing it," said Dr. Barry Farr, an infection-control expert and professor emeritus at the University of Virginia.

Systematic testing and isolation of MRSA-colonized patients isn't common practice in hospitals, although many identify hot spots of infection and address periodic outbreaks.

Patients struck by MRSA and those who have lost loved ones say they lost trust in hospitals long ago.

Dayle Stirn, 59, broke her leg in 2005 after tripping at a church function. Doctors at a nearby hospital operated, and within a week blood blisters began breaking out around Stirn's surgical wound.

Eventually, Stirn learned that she had MRSA and returned to the hospital for a second operation to remove infected tissue. "Can someone tell me, realistically, what I'm facing here?" she remembers asking doctors and nurses. Stirn said she never got a good answer.

Today, after three more surgeries, Stirn can walk only with crutches, a walker or a cane. "I went in there as a 57-year-old woman with no health problems and came out like this," she said.

Judith Graham writes for the Chicago Tribune.

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.